Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News and Analysis
  • Published:

iPS cell technology gains momentum in drug discovery

Nature Reviews Drug Discovery volume 8, pages 263–264 (2009)Cite this article

The successful reprogramming of adult cells into induced pluripotent stem (iPS) cells without viral vectors adds to the excitement about the application of iPS cells in drug discovery and development.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Authors
  1. Sarah Webb
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Webb, S. iPS cell technology gains momentum in drug discovery. Nat Rev Drug Discov 8, 263–264 (2009). https://doi.org/10.1038/nrd2867

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd2867

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing